## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.7% below STRENGTH zone (3.0-6.0%); PEG 3.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($556.08)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 1)

**1. SDA Awards $1.6 Billion in Tranche 3 Tracking Layer Contracts to Rocket Lab and Northrop Grumman**
- Source: SatNews Publishers | 20251228T151744 | Bullish | Relevance: 100%
- The Space Development Agency (SDA) has awarded $1.6 billion in contracts to Rocket Lab and Northrop Grumman for the Tranche 3 Tracking Layer of the Proliferated Warfighter Space Architecture. These contracts will fund the construction and operation of 36 satellites to enhance the Pentagon's ability to detect and track advanced missile threats. Rocket Lab will receive $805 million for 18 satellites, marking its largest contract, while Northrop Grumman will receive $764 million for 18 satellites, adding to its extensive involvement in the PWSA.

**2. Northrop Grumman awarded $100 million Contract for Stand-in Attack Weapon subsystem support**
- Source: Defence Industry Europe | 20251225T214639 | Bullish | Relevance: 100%
- The U.S. Air Force has awarded Northrop Grumman Systems Corp. a contract worth up to $100 million for long-term support of the Stand-in Attack Weapon (SiAW) Subsystem. This indefinite-delivery and indefinite-quantity agreement, announced on November 25, focuses on technical support, test and evaluation, and science and technology development rather than full system production. The work, which will be carried out in Baltimore, Maryland, is overseen by the Air Force Life Cycle Management Center and aims to enhance precision strike capabilities in contested airspace.

**3. Is It Too Late To Consider Northrop Grumman After Its Strong 2025 Share Price Rally?**
- Source: Simply Wall Street | 20251225T214539 | Somewhat-Bullish | Relevance: 100%
- Northrop Grumman has seen significant share price appreciation in 2025, driven by increased defense spending expectations and geopolitical risks. A discounted cash flow analysis suggests the stock might be 13.8% overvalued, indicating investors are paying a premium for perceived quality and safety. However, a price-to-earnings comparison suggests the stock is undervalued relative to its industry and peers, with Simply Wall St's proprietary "Fair Ratio" indicating potential undervaluation.

**4. Northrop awarded Veyron chip R&D deal**
- Source: Defence Blog | 20251224T121000 | Bullish | Relevance: 100%
- Northrop Grumman has been awarded a $59.98 million contract by the Air Force Research Laboratory for the VEYRON effort, which focuses on developing a secure digital beamforming ASIC. This project aims to integrate on-chip Root of Security features to mitigate supply chain risks in advanced military systems such as radar and electronic warfare. The work will be performed at Northrop Grumman's Linthicum Heights facility and is expected to conclude by June 30, 2028.

**5. China imposes countermeasures against 20 US defense-related companies, 10 senior executives**
- Source: Global Times | 20251226T090813 | Bearish | Relevance: 82%
- China has announced countermeasures against 20 US military-related companies and 10 senior executives in response to US arms sales to China's Taiwan Region. These measures include freezing assets within China and prohibiting transactions with the companies, and denying visas or entry into China for the executives. This decision, effective December 26, 2025, is based on China's Law on Countering Foreign Sanctions.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.08M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.76 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $82.7B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.76 |
| Forward P/E | 20.0 |
| Current P/E | 22.2 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.9% to -0.7% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.7pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.12), confirming momentum. RSI neutral at 56. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.70% (CS: 56) | Neutral |
| RSI_14 | 55.5 | Neutral |
| MACD Histogram | 3.12 | Bullish |
| vs SMA20 | 1.024x | Above |
| vs SMA50 | 1.009x | Above |
| vs SMA200 | 1.063x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $577.32
- **Stop Loss:** $556.08 (3.7% risk)
- **Target:** $598.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 38
- **Position Value:** $21,938.16
- **Portfolio %:** 21.94%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*